SMARCA4 and non-small cell lung carcinoma: In a different study with the largest number of SMARCA4 mutations in this review (N = 3305), the authors focused on clinicopathologic characteristics of patients with SMARCA4 mutations and BRG1-deficient NSCLC [6].